Learn from Industry Experts
Watch our webinars to gain insight into industry trends, medical discoveries, health technology and much more.
- Brands
- Offerings
- Diagnostic Panels
- Events
- Knowledge Center
- Diagnostics
Core Laboratory
Core Laboratory
Welcome to the Knowledge Center
Choose from a variety of resources to learn more about the fundamentals of laboratory science, uncover new methodologies like Total Value of Ownership and gain ideas to propel your healthcare institution forward
Infectious Disease
Identifying Untreated Hepatitis B and C Maximizing Early Detection of Liver Disease Increased Blood Donor Engagement and Safe Blood Supply Cardiac
Improved Emergency Patient Flow ADP for Suspected ACS Patients Increased Accuracy for the Diagnosis of Acute Myocardial Infarction KIDNEY
Co-reporting of eGFRs to Optimize PharmocotherapiesImproved Diagnostic Pathway For Acute Kidney Injury 
Resources that advance
your laboratory
Abbott has developed a library of digital resources to help you in your work. Use these publications to keep abreast of the latest information in laboratory science, important therapeutic areas, and how Abbott has contributed to the industry.
COVID-19 white Papers
Health System CEOs from across the US discovered three common themes, regardless of location and incidence of COVID-19, that health systems and their communities faced and are continuing to face during this pandemic. Find out why we need to focus on:
- Building the Community
- Building Confidence
- Building the Future
creating value in the lab
TOTAL VALUE OF OWNERSHIP
Total Cost of Ownership
Analyzing the laboratory with a Total Value of Ownership (TVO) methodology can unlock a wealth of possibilities to deliver value. Learn how three laboratories from around the world applied TVO to help them to reach their goals.
Total Cost of Ownership (TCO) provides a structured approach to analyzing all direct and indirect instrument costs. Discover how several analytic platforms compare in three key areas: maintenance time, processing time and utility consumption.
Infectious Disease
The Economist:
Egpyt's Path to Eliminating Hepatitis
THE ECONOMIST:
TAKING AIM: THE POLICY RESPONSE TO VIRAL HEPATITIS IN UGANDA
THE ECONOMIST:
PAKISTAN RENEWS FIGHT AGAINST BURGEONING HEPATITIS BURDEN
The prevalence of Hepatitis C in Egypt was unlike any other country in the world. Discover why Egypt now appears to be on the path to successfully eliminating viral Hepatitis and how their approach can offer valuable lessons to other countries.
There is evidence that viral Hepatitis is a growing danger in Uganda. However, a lack of data made it difficult to create a strategic plan for the way forward. Learn about Uganda's multifaceted policy response to address this important issue.
The scale of Hepatitis C in Pakistan required elevation to a public health priority after past inadequate action, while Hepatitis B declined with a successful vaccination program. Explore Pakistan's renewed commitment to fighting both Hepatitis C and B.
BIOTIN INTERFERENCE
Scientific updates Assessment of on-market assays, FDA Recommendations and FAQ
Stay up-to-date with the latest regulations and medical uses for Biotin and develop your knowledge on assay interference that has the potential to result in false results that can be critical to patient safety and your laboratory practice.
Learn more about Biotin risks and find additional resources to help you stay aware of adverse events.
Archive
View our archive collection of publications that can be used to build upon current knowledge or aid in additional research for in-lab personel or management.
| Publication | Description |
| DIABETES: Assessing Analytical Quality of HbA1c Assays Using Sigma Metrics |
HbA1c is a critical assay as a result of the worldwide diabetes epidemic. Read the study to view the analytical performance of four HbA1c commercial assays using accuracy based grading and Sigma metrics. |
Critical education for your team
Build key laboratory competencies to better serve physicians and patients with our learning guides.
Join the conversation
Follow the Abbott Diagnostics LinkedIn channel for the latest news from our company and within the in vitro diagnostics industry.
You are about to exit the Abbott family of websites for a 3rd party website
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Do you wish to continue and exit this website?
Yes NoYou are about to enter an Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.